ES2194854T3 - Composiciones farmaceuticas que contienen acido tioctico o dihidroliponico en forma de compuestos de inclusion con ciclodextrinas y en forma de granulados, comprimidos para mascar o efervescentes. - Google Patents

Composiciones farmaceuticas que contienen acido tioctico o dihidroliponico en forma de compuestos de inclusion con ciclodextrinas y en forma de granulados, comprimidos para mascar o efervescentes.

Info

Publication number
ES2194854T3
ES2194854T3 ES94116380T ES94116380T ES2194854T3 ES 2194854 T3 ES2194854 T3 ES 2194854T3 ES 94116380 T ES94116380 T ES 94116380T ES 94116380 T ES94116380 T ES 94116380T ES 2194854 T3 ES2194854 T3 ES 2194854T3
Authority
ES
Spain
Prior art keywords
cyclodextrin
acid
granulates
medicament
effervescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94116380T
Other languages
English (en)
Inventor
Helmut Dr Hettche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Viatris GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6502345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2194854(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Viatris GmbH and Co KG filed Critical Viatris GmbH and Co KG
Application granted granted Critical
Publication of ES2194854T3 publication Critical patent/ES2194854T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL SABOR DESAGRADABLE DEL ACIDO TIOCTICO O DEL ACIDO DIHIDROLIPONICO SE PUEDE TAPAR MEDIANTE INCRUSTACION EN CICLODEXTRINA. SE DESCRIBEN FORMAS MEDICINALES PARA ELLO. SON NUEVOS LOS COMPUESTOS DE INCLUSION A BASE DE ACIDO DIHIDROLIPONICO PURIFICADO DE ENANTIOMEROS, ACIDO TIOCTICO Y CICLODEXTRINAS. SON APROPIADOS PARA LA ELABORACION DE MEDICAMENTOS.
ES94116380T 1993-11-11 1994-10-18 Composiciones farmaceuticas que contienen acido tioctico o dihidroliponico en forma de compuestos de inclusion con ciclodextrinas y en forma de granulados, comprimidos para mascar o efervescentes. Expired - Lifetime ES2194854T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4338508A DE4338508A1 (de) 1993-11-11 1993-11-11 Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten

Publications (1)

Publication Number Publication Date
ES2194854T3 true ES2194854T3 (es) 2003-12-01

Family

ID=6502345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94116380T Expired - Lifetime ES2194854T3 (es) 1993-11-11 1994-10-18 Composiciones farmaceuticas que contienen acido tioctico o dihidroliponico en forma de compuestos de inclusion con ciclodextrinas y en forma de granulados, comprimidos para mascar o efervescentes.

Country Status (8)

Country Link
EP (2) EP0654484B1 (es)
JP (1) JP3404435B2 (es)
AT (1) ATE238352T1 (es)
CA (1) CA2135535C (es)
DE (2) DE4338508A1 (es)
DK (1) DK0654484T3 (es)
ES (1) ES2194854T3 (es)
PT (1) PT654484E (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510130C1 (de) * 1995-03-21 1996-11-21 Asta Medica Ag Verfahren zur Herstellung rieselfähiger R,S-Thioctsäure, R,S-Thioctsäure sowie deren Verwendung
DE19705555A1 (de) * 1997-02-13 1998-08-20 Ulrich Dr Posanski Pharmazeutische Präparate der Thioctsäure zur oralen Anwendung
NZ330596A (en) 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
US6905707B2 (en) 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
CN1144585C (zh) * 2000-12-13 2004-04-07 华扩达动物科学[I.P.2]有限公司 含有半胱胺或其盐类的促进动物快速生长的组合物及用途
JP4849792B2 (ja) * 2004-09-14 2012-01-11 オリザ油化株式会社 美容用組成物
DE102004060914A1 (de) * 2004-12-17 2006-07-06 Bioghurt Biogarde Gmbh & Co. Kg Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen
EP1707217A1 (en) 2004-12-17 2006-10-04 Wacker Chemie AG Process for preparing an alpha lipoic acid/cyclodextrin complex and product prepared
EP1671653B1 (en) * 2004-12-17 2007-08-01 Wacker Chemie AG Process for preparing an alpha lipoic acid/cyclodextrin complex and product prepared
JP5011776B2 (ja) * 2005-03-28 2012-08-29 大正製薬株式会社 銅化合物配合組成物
JP5157001B2 (ja) * 2005-04-30 2013-03-06 ビーエイチエヌ株式会社 安定化α−リポ酸組成物及びその利用
JP4951226B2 (ja) * 2005-09-08 2012-06-13 立山化成株式会社 α−リポ酸アルカリ塩の製法
JP5023311B2 (ja) * 2005-11-06 2012-09-12 ビーエイチエヌ株式会社 皮膚障害の改善及び／又は予防のための組成物
JP2007177149A (ja) * 2005-12-28 2007-07-12 Shield Lab:Kk チオクト酸又はジヒドロリポ酸と分岐鎖シクロデキストリンとの包接化合物
JP5044767B2 (ja) * 2006-01-28 2012-10-10 ビーエイチエヌ株式会社 色素沈着阻害剤及びその利用
JP2009108019A (ja) * 2007-10-30 2009-05-21 Bhn Kk 紫外線抵抗力増強用皮膚外用剤
RU2552927C2 (ru) * 2010-03-13 2015-06-10 Истпонд Лабораториз Лимитед Жиросвязывающая композиция
WO2012014746A1 (ja) * 2010-07-30 2012-02-02 株式会社シクロケム αリポ酸複合体
US20160235709A1 (en) 2012-08-31 2016-08-18 Molecular product management LLC Limited release lingual thioctic acid delivery systems
WO2013033662A1 (en) * 2011-08-31 2013-03-07 Zolentroff, William, C. Limited release lingual thioctic acid delivery systems
EP3519812A4 (en) 2016-09-27 2020-06-17 Zolentroff, William C. FORMULATION OF ALA AND SALT
EP4194448A1 (en) * 2020-08-27 2023-06-14 Kyowa Pharma Chemical Co., Ltd. Trisulfide compound and clathrate thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520942A (en) * 1976-02-10 1978-08-09 Ono Pharmaceutical Co Postaglandin analogues
HU176217B (en) * 1978-11-20 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-chamomille inclusion complex and compositions containing thereof
HU177081B (en) * 1978-12-12 1981-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing the occlusion complex of allicin with cyclodextrin
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU190841B (en) * 1983-02-04 1986-11-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for the production of cyclodextrin polymers swelling in water quickly and to a high extent
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
ATE124422T1 (de) * 1989-04-12 1995-07-15 Procter & Gamble Festes verbraucherprodukt, welches feinteilige cyclodextrin-komplexe enthält.
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
JPH03169813A (ja) * 1989-11-09 1991-07-23 Asta Pharma Ag 細胞保護作用を有する疼痛及び炎症性疾患及び／又はレトロウイルスに起因する病気の治療用医薬並びにその製法
AT500684B8 (de) * 1989-11-09 2006-11-15 Meda Pharma Gmbh & Co Kg Verwendung von schwefelhältigen carbonsäuren zur herstellung eines arzneimittels zur bekämpfung von erkrankungen durch retroviren
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2659970A1 (fr) * 1990-03-26 1991-09-27 Santerre Orsan Procede de preparation de composes d'inclusion a base de cyclodextrine et composes d'inclusion obtenus.
US5139687A (en) * 1990-05-09 1992-08-18 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E

Also Published As

Publication number Publication date
CA2135535C (en) 2006-03-21
DE4338508A1 (de) 1995-05-18
DE59410277D1 (de) 2003-05-28
EP0654484B1 (de) 2003-04-23
ATE238352T1 (de) 2003-05-15
JPH07188304A (ja) 1995-07-25
EP0654484A3 (de) 1995-08-16
DK0654484T3 (da) 2003-07-28
EP1063241A1 (de) 2000-12-27
EP0654484A2 (de) 1995-05-24
CA2135535A1 (en) 1995-05-12
PT654484E (pt) 2003-08-29
JP3404435B2 (ja) 2003-05-06

Similar Documents

Publication Publication Date Title
ES2194854T3 (es) Composiciones farmaceuticas que contienen acido tioctico o dihidroliponico en forma de compuestos de inclusion con ciclodextrinas y en forma de granulados, comprimidos para mascar o efervescentes.
BR0311959A (pt) Composição, método para preparar um polipeptìdeo estável do fator vii, e para tratar uma sìndrome responsiva do fator vii, e, uso do polipeptìdeo do fator vii
ATE187887T1 (de) Verzögerte freigabe matrix für arzneimittel
ES8707110A1 (es) Un procedimiento para preparar una composicion farmaceutica oral, de accion prolongada, en forma de dosificacion unitaria solida.
HUP0104472A2 (hu) Nyújtott leadású mátrix jól oldódó hatóanyagokhoz
EE9900589A (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
DK0460062T3 (da) Huperzin A-analoger
EA200001201A2 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
AR002979A1 (es) Composicion de maltitol y proceso para su preparacion
HUP0301919A2 (hu) Szabályozott pH tartományban levż stabil gabapentin
ES2045230T3 (es) Preparado de tipo de absorcion percutanea y procedimiento de su preparacion.
DK1332679T3 (da) Anvendelse af erythritol i tyggegummisammensætning
DK0468245T3 (da) Tablet og granulat indeholdende mesna som aktivt middel
JPS55157513A (en) Plasma expander
JPS57137351A (en) Resin composition containing perfumery
JPS5318655A (en) Chlorine-containing resin composition
SE7901203L (sv) O-substituerade oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra, sett for framstellning och anvendning derav som lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
AU2001242965A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
ES2091983T3 (es) Procedimiento para estabilizar dibencilidensorbitoles y una composicion de los mismos.
JPS5551018A (en) Carcinostatic agent
ES2171056T3 (es) Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
ES2106907T3 (es) Agente para dejar de fumar.
JPS54154719A (en) Method of preventing paradichlorobenzene from blocking
Espinosa Rodriguez The Nazarene movement and its impact on Maltese nineteenth century art
JPS57153076A (en) Heat accumulating material